Credit Suisse’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $49.6K | Sell |
|
|||||
|
2023
Q4 | $57.6K | Buy |
|
|||||
|
2023
Q3 | $17.4K | Sell |
|
|||||
|
2023
Q2 | $28.2K | Sell |
|
|||||
|
2023
Q1 | $106K | Buy |
|
|||||
|
2022
Q4 | $386K | Buy |
|
|||||
|
2022
Q3 | $108K | Sell |
|
|||||
|
2022
Q2 | $304K | Buy |
|
|||||
|
2022
Q1 | $86K | Sell |
|
|||||
|
2021
Q4 | $1.01M | Sell |
|
|||||
|
2021
Q3 | $3.12M | Buy |
|
|||||
|
2021
Q2 | $2.11M | Sell |
|
|||||
|
2021
Q1 | $3.26M | Buy |
|
|||||
|
2020
Q4 | $2.14M | Sell |
|
|||||
|
2020
Q3 | $37M | Buy |
|
|||||
|
2020
Q2 | $43.9M | Sell |
|
|||||
|
2020
Q1 | $28.1M | Buy |
|
|||||
|
2019
Q4 | $52.9M | Sell |
|
|||||
|
2019
Q3 | $34.9M | Sell |
|
|||||
|
2019
Q2 | $49.4M | Sell |
|
|||||
|
2019
Q1 | $46.1M | Buy |
|
|||||
|
2018
Q4 | $44.7M | Buy |
|
|||||
|
2018
Q3 | $43.1M | Sell |
|
|||||
|
2018
Q2 | $42.9M | Buy |
|
|||||
|
2018
Q1 | $78.5M | Buy |
|
|||||
|
2017
Q4 | $66.9M | Sell |
|
|||||
|
2017
Q3 | $53.3M | Sell |
|
|||||
|
2017
Q2 | $51.5M | Buy |
|
|||||
|
2017
Q1 | $31M | Buy |
|
|||||
|
2016
Q4 | $8.71M | Buy |
|
|||||
|
2016
Q3 | $5.4M | Buy |
|
|||||
|
2016
Q2 | $2.94M | Buy |
|
|||||
|
2016
Q1 | $1.11M | Sell |
|
|||||
|
2015
Q4 | $1.79M | Buy |
|
|||||
|
2015
Q3 | $1.17M | Sell |
|
|||||
|
2015
Q2 | $5.71M | Buy |
|
|||||
|
2015
Q1 | $4.04M | Buy |
|
|||||
|
2014
Q4 | $794K | Buy |
|